StemCell Therapy

Scientists have recently developed ways to measure your immune age. Fortunately, it turns out your immune age can go down as well as up. And there are some simple ways to turn back the clock on your immune system.

One studyin older adults showed that those who got 10,000 steps a day on average had neutrophils as good as a young adult.

Exercise also has benefits for your T cells. Before they are released onto active duty, T-cells mature in a little-known organ called the thymus gland in your chest. The thymus degenerates over time, resulting in a drop-off in the number of T cells.

Physical activity has a huge effect on the rate of this degeneration. A study found that amateur cyclists aged between 55 and 79 had youthful thymus glands and their T-cell counts were similar to those of much younger people.

Another key factor in your immune age is your gut bacteria. There is good evidence that poor gut health is a cause of premature ageing and that a healthy microbiome can reduce your immune age. Eating a healthy, varied diet rich in fibre, plant matter and fermented foods can help maintain a healthy community of gut microbes.

Your body has a highly evolved, intricate defence system thats effective at keeping you well, but only if you look after it.

Read the original post

Read the original:
Video: How to boost your immune system to guard against COVID and other illnesses - Genetic Literacy Project

After receiving a heavy infusion of monoclonal antibodies to treat his bout of Covid-19, President Trump has declared that he is immune to the virus that causes it and talked privately about wearing a Superman T-shirt under his dress shirt when he left the hospital.

Even as the president has exulted in his supposed imperviousness to the coronavirus that is resurging across parts of the country, he has delighted in portraying former Vice President Joseph R. Biden Jr. as vulnerable and cloistered, wearing masks every time you see him.

But even if the president were now immune to the coronavirus, he may not remain so, scientists warn. The presidents unique treatment may have prevented his body from making the antibodies necessary for long-term protection.

The monoclonal antibodies he received were produced by the drug company Regeneron and will wane in a matter of weeks, as the synthetic molecules are known to do. Without replenishment, this decline may leave Mr. Trump even more susceptible to the virus than most patients who have recovered from Covid-19, several experts warned.

Moreover, the steroid treatment the president received early in the course of his illness suppresses the bodys natural immune response, including its propensity to make antibodies of its own.

He may be not protected the second time around, especially because he didnt develop his own antibodies, said Akiko Iwasaki, an immunologist at Yale University.

Most people who are infected with the coronavirus produce antibodies to the virus that should protect them from a second infection. Its unclear how long this immunity lasts; based on research into other coronaviruses, immunity may persist for up to a year, experts have said.

Keep up with Election 2020

But Mr. Trumps case is unique.

He announced his diagnosis early on Oct. 2, and a test did not pick up any antibodies in his blood, according to a report released by his physician, Dr. Sean Conley.

The lack of antibodies that early in the course of illness is not unusual. It can take from 10 days to three weeks for powerful antibodies to surface.

If he had tested positive, then we would know for sure that he has his own antibodies, said Dr. Dan Barouch, a virologist at Beth Israel Deaconess Medical Center in Boston.

Since he was antibody-negative, it is less likely but not ruled out, he added. He could have been in the early stage of generating his own antibodies. (Dr. Barouch is an investigator for Regenerons trial of the cocktail for preventing coronavirus infections.)

On Oct. 2, Mr. Trump received eight grams of a cocktail of two monoclonal antibodies made by Regeneron. These antibodies are infused into people like those of Mr. Trumps age, sex and weight who may struggle to produce an immune response of their own.

A test on Oct. 5 confirmed the presence of the antibodies, according to Dr. Conley.

But Dr. Barouch noted that the antibodies detected in the bloodstream are not his antibodies. Theyre antibodies that were administered. Those antibodies will wane over time.

Oct. 16, 2020, 9:19 p.m. ET

The monoclonal antibodies may have quickly suppressed the level of virus in Mr. Trumps body. While this may have protected the president from severe symptoms, it may also have prevented his immune system from making its own antibodies.

If you get the antibodies early on, and you either prevent or rapidly treat infections, Dr. Barouch said, then you probably will actually inhibit the generation of your own bodys antibodies.

Mr. Trump was also treated with dexamethasone, a steroid that is known to suppress the immune system. And he received it much earlier in the course of his illness than usual.

That also may suppress a patients antibody response, said Kartik Chandran, a virologist at Albert Einstein College of Medicine in the Bronx.

Older people and men are already less likely to generate it, he added, referring to antibodies. You add dexamethasone to the mix and God knows.

Mr. Trump received a huge dose of the antibodies, but blood levels are expected to fall by half between 21 to 25 days from infusion. Values in this range are sufficient to support monthly dosing, according to information provided by Regeneron.

The White House did not respond to questions about whether Mr. Trump intends to take monthly doses of the cocktail.

Regeneron has said that it has 50,000 doses of the cocktail in hand, and that it would need to begin rationing the therapy if the drug were to be widely distributed.

In a clinical trial, the drug maker is evaluating whether people given the cocktail make their own antibodies, but has not yet completed the analysis, according to a spokeswoman.

Monoclonal antibodies are generally considered to be safe and effective, but Regenerons cocktail has not yet been rigorously tested in clinical trials. A trial of a monoclonal antibody made by Eli Lilly was paused on Tuesday because of a safety concern.

Mr. Trump has endorsed both treatments and repeatedly declared his immunity to the coronavirus.

Im immune I could come down and start kissing everybody, he said at a rally on Tuesday in Jonesboro, Pa. Ill kiss every guy. Man and woman. Look at that guy, how handsome he is. Ill kiss him. Not with a lot of enjoyment, but thats OK.

Originally posted here:
For How Long Will President Trump Be Immune to the Coronavirus? - The New York Times

Vanderbilt University researchers have reported the counterintuitive discovery that certain chemotherapeutic agents used to treat tumors can have the opposite effect of tissue overgrowth in normal, intact mammary glands, epidermis and hair follicles. The researchers also are the first to report the discovery of an innate immune signaling pathway in fibroblaststhe spindle-shaped cells responsible for wound healing and collagen productionthat causes cells to proliferate. Such signaling pathways previously were attributed only to immune cells.

The article describing the research, DNA Damage Promotes Epithelial Hyperplasia and Fate Mis-specification via Fibroblast Inflammasome Activation, was published in the journal Developmental Cell on Oct. 13.

The findings of this work, led by postdoctoral fellow Lindsey Seldin and Professor and Chair of the Department of Cell and Developmental Biology Ian Macara, have broad implications for diseases associated with the immune system like psoriasis, as well as cancer and stem cell research.

Understanding the functionality of stem cells and the way that their behavior is regulated has been a longstanding research interest for Seldin. Normal stem cells have an amazing ability to continuously divide to maintain tissue function without forming tumors, she explained. We wanted to understand what happens to these cells in their native environment when subjected to damage, and if the response was connected to a specific tissue.

By testing perturbations to the epidermis, mammary gland and hair follicles vis--vis mechanical damage or DNA damage through chemotherapeutic agents, the researchers saw a paradoxical response: Stem cells, which otherwise would divide slowly, instead divided rapidly, promoting tissue overgrowth.

When the tissues were subjected to DNA damage, their stem cells overly proliferated, giving rise to different cells than they normally would. This was a very perplexing result, said Seldin, the papers lead author. We were determined to figure out if this was a direct response by the stem cells themselves or by inductive signals within their environment. The key clue was that stem cells isolated from the body did not behave the same way as in intact tissuean indication that the response must be provoked from signals being sent to the stem cells from other surrounding cell types.

The investigators turned their attention to fibroblasts, the predominant component of the tissue microenvironment. When fibroblasts in the epidermis were removed, the stem cell responsiveness to DNA damage was diminished, indicating that they played an important role. RNA sequencing revealed that fibroblasts can signal by way of inflammasomescomplexes within cells that help tissues respond to stress by clearing damaged cells or pathogens, which also in this case caused stem cells to divide. This is an astounding discovery, said Macara. Inflammasome signaling has previously been attributed only to immune cells, but now it seems that fibroblasts can assume an immune-like nature.

Seldin intends to replicate this work in the mammary gland to determine whether fibroblasts initiate the same innate immune response as in the epidermis, and more broadly how fibroblasts contribute to the development of cancer and other diseases associated with the immune system.

This work was supported by NCI/NIH grants R35CA132898, F32CA213794 and T32CA119925, as well as American Cancer Society grant PF-18-007-01-CCG.

Follow this link:
Vanderbilt researchers make counterintuitive discoveries about immune-like characteristics of cells, chemotherapys impact on tissue growth -...

Reports of reinfection with the coronavirus evoke a nightmarish future: Repeat bouts of illness, impotent vaccines, unrelenting lockdowns a pandemic without an end.

A case study published on Monday, about a 25-year-old man in Nevada, has stoked those fears anew. The man, who was not named, became sicker the second time that he was infected with the virus, a pattern the immune system is supposed to prevent.

But these cases make the news precisely because they are rare, experts said: More than 38 million people worldwide have been infected with the coronavirus, and as of Monday, fewer than five of those cases have been confirmed by scientists to be reinfections.

Thats tiny its like a microliter-sized drop in the bucket, compared to the number of cases that have happened all over the world, said Angela Rasmussen, a virologist at Columbia University in New York.

In most cases, a second bout with the virus produced milder symptoms or none at all. But for at least three people, including one patient in Ecuador, the illness was more severe the second time around than during the first infection. An 89-year-old woman in the Netherlands died during her second illness.

Rare as these cases may be, they do indicate that reinfection is possible, said Akiko Iwasaki, an immunologist at Yale University, who wrote a commentary accompanying the Nevada case study, published in The Lancet Infectious Diseases.

Its important to note that there are people who do get reinfected, and in some of those cases you get worse disease, Dr. Iwasaki said. You still need to keep wearing masks and practice social distancing even if you have recovered once from this infection.

We asked experts what is known about reinfections with the coronavirus, and what the phenomenon means for vaccinations and the course of the pandemic.

First, the good news: Reinfection seems to be vanishingly rare.

Since the first confirmed case of reinfection, reported in Hong Kong on Aug. 24, there have been three published cases; reports of another 20 await scientific review.

But its impossible to know exactly how widespread the phenomenon is. To confirm a case of reinfection, scientists must look for significant differences in the genes of the two coronaviruses causing both illnesses.

In the United States, where testing was a rare resource much of this year, many people were not tested unless they were sick enough to be hospitalized. Even then, their samples were usually not preserved for genetic analysis, making it impossible to confirm suspected reinfections.

A vast majority of people who do get reinfected may go undetected. For example, the man in Hong Kong had no symptoms the second time, and his infection was discovered only because of routine screening at the airport.

There are a lot of people that are going to also have been exposed that arent having symptoms, that were never going to hear about, said Marion Pepper, an immunologist at the University of Washington in Seattle.

People whose second infections are more severe are more likely to be identified, because they return to the hospital. But those are likely to be even rarer, experts said.

If this was a very common event, we would have seen thousands of cases, Dr. Iwasaki said.

Reinfections can occur for any number of reasons: because the initial infection was too mild to produce an immune response, for example, or because the immune system was compromised by other health conditions. On occasion, a patient may be exposed to a large amount of virus that seeded an infection before the immune response could respond.

This variability is entirely expected, experts said, and has been observed in patients with diseases like measles and malaria.

Youll never have the distribution of anything with millions of people where you dont have some very severe rare cases happening at the fringe, said Dr. Michael Mina, a pediatric immunologist at the Harvard T.H. Chan School of Public Health.

At least two of the reinfected patients in Europe had compromised immune systems, for example, and the 89-year-old woman who died was receiving chemotherapy. In other reinfected patients, genetic factors or the lack of certain previous immune exposures may have blunted the bodys ability to fight off a second attack.

There are some people who just dont develop good immune responses to certain pathogens, said Florian Krammer, an immunologist at the Icahn School of Medicine at Mount Sinai. What is causing that? Were not sure, but its rare, usually.

In a vast majority of known infected patients, experts said, the immune system functions as it should against other pathogens.

There are a lot of different infections where you can get re-exposed to the virus, and we would probably not know because you dont have symptoms, Dr. Pepper said. And that might be an important part of boosting immunity.

When the body is exposed to an unfamiliar virus, its normal first to develop some immunity and then to increase that response with each additional exposure. This phenomenon is well known among children, but it is less often seen in adults because they rarely encounter new viruses, Dr. Mina said.

I think its important to recognize that reinfections are literally embedded in the evolution of our immune system, he added. We sometimes lose track of that with so many people talking about this who really havent studied the immune system.

For every confirmed case of reinfection, there are dozens of anecdotal reports of infected people who were sick and seemingly recovered but then became ill again weeks to months later.

Usually there are crucial data missing in those cases, like a confirmed lab diagnosis, or a virus sample that can be sequenced.

The question is always, Is it a real reinfection? Dr. Krammer said. Its very often very challenging to kind of get that kind of data.

A vast majority of these cases are unlikely to be true infections. More likely, these are people experiencing a resurgence of symptoms connected to the original infection. The virus may set off an inflammatory response that can flare up even weeks later and cause symptoms like fatigue and heart problems. In rare cases, some patients may develop a chronic low-grade infection with the virus that never quite goes away.

Even with viruses that can cause acute infections, like flu, Dr. Krammer said, you can have persistent infections if your immune system is sufficiently compromised.

Although these are not real reinfections, they are still worrying if they lead to renewed illness or hospitalization months after the initial infection, Dr. Rasmussen said. If theres recrudescence happening frequently, and people are getting severely ill the second time around, thats potentially its own problem, she said.

Reinfected people without symptoms may still transmit the virus to others. The patient in Hong Kong, for example, was isolated in a hospital even though he had no symptoms. But his viral load was high enough that he could have passed the virus to others.

Obviously, that person wasnt ill, so it bodes well for him, but it doesnt bode well for the community, Dr. Pepper said.

But to be sure of infectiousness, researchers may need to look for live virus. South Korean researchers investigated hundreds of reports of reinfection and were able to rule them out as real cases after failing to grow infectious virus from the samples.

Similar procedures would be needed to rule out the possibility of transmission in each patient, Dr. Rasmussen said, adding, I think thats the only way youd be able to get to the bottom of that.

Reports of reinfection have raised concerns about whether vaccines for the coronavirus will be effective and help communities achieve population immunity. The worry is that the immunity produced by vaccines will not be sufficient in preventing reinfections with the virus.

In reality, experts said, vaccines have a better chance at generating robust immunity than does natural infection with the virus.

For example, the coronavirus is particularly adept at dodging the bodys early immune alarms, buying valuable time to seed an infection. In some people, this lag eventually triggers a cascading immune overreaction that can be more harmful than the infection itself.

Vaccines are intended to unfurl an immune response without interference from the virus, and thus may avoid this inflammatory sequence. Vaccines can also be manipulated to enhance immune memory, in that way producing more lasting, more protective responses.

Vaccine trials are designed to look for an absence of disease, rather than of infection, and its unclear whether vaccines can suppress virus levels enough to prevent transmission to others.

Still, vaccine-induced immunity should perform better than natural immunity, Dr. Rasmussen said, adding, Im optimistic.

Originally posted here:
Coronavirus Reinfections Are Real but Very, Very Rare - The New York Times

For an outstanding business growth, companies must take up market research report service which is vital in todays market place. An influential Exosome Therapeutic Market report also offers top to bottom examination of the market for estimating income, return on investment (ROI) and developing business strategies. This market research report helps out the business in every sphere of trade to take the unmatched decisions, to tackle the toughest business questions and diminish the risk of failure. The industry report highlights general market conditions, estimates market share and possible sales volume of industry. The facts and figures described in this Exosome Therapeutic Market document aids industry in taking sound decisions and planning advertising and sales strategy more successfully.

Get Sample PDF (including COVID19 Impact Analysis) of Market Report @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-exosome-therapeutic-market&rp

Market Analysis and Insights:Global Exosome Therapeutic Market

Exosome therapeutic market is expected to gain market growth in the forecast period of 2019 to 2026. Data Bridge Market Research analyses that the market is growing with a CAGR of 21.9% in the forecast period of 2019 to 2026 and expected to reach USD 31,691.52 million by 2026 from USD 6,500.00 million in 2018. Increasing prevalence of lyme disease, chronic inflammation, autoimmune disease and other chronic degenerative diseases are the factors for the market growth.

The major players covered in theExosome Therapeutic Marketreport areevox THERAPEUTICS, EXOCOBIO, Exopharm, AEGLE Therapeutics, United Therapeutics Corporation, Codiak BioSciences, Jazz Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, ReNeuron Group plc, Capricor Therapeutics, Avalon Globocare Corp., CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC., Stem Cells Group among other players domestic and global.Exosome therapeutic market share data is available for Global, North America, Europe, Asia-Pacific, and Latin America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Get Full TOC, Tables and Figures of Market Report @https://www.databridgemarketresearch.com/toc/?dbmr=global-exosome-therapeutic-market&rp

Exosomes are used to transfer RNA, DNA, and proteins to other cells in the body by making alteration in the function of the target cells. Increasing research activities in exosome therapeutic is augmenting the market growth as demand for exosome therapeutic has increased among healthcare professionals.

Increased number of exosome therapeutics as compared to the past few years will accelerate the market growth. Companies are receiving funding for exosome therapeutic research and clinical trials. For instance, In September 2018, EXOCOBIO has raised USD 27 million in its series B funding. The company has raised USD 46 million as series a funding in April 2017. The series B funding will help the company to set up GMP-compliant exosome industrial facilities to enhance production of exosomes to commercialize in cosmetics and pharmaceutical industry.

Increasing demand for anti-aging therapies will also drive the market. Unmet medical needs such as very few therapeutic are approved by the regulatory authority for the treatment in comparison to the demand in global exosome therapeutics market will hamper the market growth market. Availability of various exosome isolation and purification techniques is further creates new opportunities for exosome therapeutics as they will help company in isolation and purification of exosomes from dendritic cells, mesenchymal stem cells, blood, milk, body fluids, saliva, and urine and from others sources. Such policies support exosome therapeutic market growth in the forecast period to 2019-2026.

This exosome therapeutic market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for anAnalyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Global Exosome Therapeutic Market Scope and Market Size

Global exosome therapeutic market is segmented of the basis of type, source, therapy, transporting capacity, application, route of administration and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Based on type, the market is segmented into natural exosomes and hybrid exosomes. Natural exosomes are dominating in the market because natural exosomes are used in various biological and pathological processes as well as natural exosomes has many advantages such as good biocompatibility and reduced clearance rate compare than hybrid exosomes.

Exosome is an extracellular vesicle which is released from cells, particularly from stem cells. Exosome functions as vehicle for particular proteins and genetic information and other cells. Exosome plays a vital role in the rejuvenation and communication of all the cells in our body while not themselves being cells at all. Research has projected that communication between cells is significant in maintenance of healthy cellular terrain. Chronic disease, age, genetic disorders and environmental factors can affect stem cells communication with other cells and can lead to distribution in the healing process. The growth of the global exosome therapeutic market reflects global and country-wide increase in prevalence of autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases, along with increasing demand for anti-aging therapies. Additionally major factors expected to contribute in growth of the global exosome therapeutic market in future are emerging therapeutic value of exosome, availability of various exosome isolation and purification techniques, technological advancements in exosome and rising healthcare infrastructure.

Rising demand of exosome therapeutic across the globe as exosome therapeutic is expected to be one of the most prominent therapies for autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases treatment, according to clinical researches exosomes help to processes regulation within the body during treatment of autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases. This factor has increased the research activities in exosome therapeutic development around the world for exosome therapeutic. Hence, this factor is leading the clinician and researches to shift towards exosome therapeutic. In the current scenario the exosome therapeutic are highly used in treatment of autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases and as anti-aging therapy as it Exosomes has proliferation of fibroblast cells which is significant in maintenance of skin elasticity and strength.

Based on source, the market is segmented into dendritic cells, mesenchymal stem cells, blood, milk, body fluids, saliva, urine and others. Mesenchymal stem cells are dominating in the market because mesenchymal stem cells (MSCs) are self-renewable, multipotent, easily manageable and customarily stretchy in vitro with exceptional genomic stability. Mesenchymal stem cells have a high capacity for genetic manipulation in vitro and also have good potential to produce. It is widely used in treatment of inflammatory and degenerative disease offspring cells encompassing the transgene after transplantation.

Based on therapy, the market is segmented into immunotherapy, gene therapy and chemotherapy. Chemotherapy is dominating in the market because chemotherapy is basically used in treatment of cancer which is major public health issues. The multidrug resistance (MDR) proteins and various tumors associated exosomes such as miRNA and IncRNA are include in in chemotherapy associated resistance.

Based on transporting capacity, the market is segmented into bio macromolecules and small molecules. Bio macromolecules are dominating in the market because bio macromolecules transmit particular biomolecular information and are basically investigated for their delicate properties such as biomarker source and delivery system.

Based on application, the market is segmented into oncology, neurology, metabolic disorders, cardiac disorders, blood disorders, inflammatory disorders, gynecology disorders, organ transplantation and others. Oncology segment is dominating in the market due to rising incidence of various cancers such as lung cancer, breast cancer, leukemia, skin cancer, lymphoma. As per the National Cancer Institute, in 2018 around 1,735,350 new cases of cancer was diagnosed in the U.S. As per the American Cancer Society Inc in 2019 approximately 268,600 new cases of breast cancer diagnosed in the U.S.

Based on route of administration, the market is segmented into oral and parenteral. Parenteral route is dominating in the market because it provides low drug concentration, free from first fast metabolism, low toxicity as compared to oral route as well as it is suitable in unconscious patients, complicated to swallow drug etc.

The exosome therapeutic market, by end user, is segmented into hospitals, diagnostic centers and research & academic institutes. Hospitals are dominating in the market because hospitals provide better treatment facilities and skilled staff as well as treatment available at affordable cost in government hospitals.

Exosome therapeutic Market Country Level Analysis

The global exosome therapeutic market is analysed and market size information is provided by country by type, source, therapy, transporting capacity, application, route of administration and end user as referenced above.

The countries covered in the exosome therapeutic market report are U.S. and Mexico in North America, Turkey in Europe, South Korea, Australia, Hong Kong in the Asia-Pacific, Argentina, Colombia, Peru, Chile, Ecuador, Venezuela, Panama, Dominican Republic, El Salvador, Paraguay, Costa Rica, Puerto Rico, Nicaragua, Uruguay as part of Latin America.

Country Level Analysis, By Type

North America dominates the exosome therapeutic market as the U.S. is leader in exosome therapeutic manufacturing as well as research activities required for exosome therapeutics. At present time Stem Cells Group holding shares around 60.00%. In addition global exosomes therapeutics manufacturers like EXOCOBIO, evox THERAPEUTICS and others are intensifying their efforts in China. The Europe region is expected to grow with the highest growth rate in the forecast period of 2019 to 2026 because of increasing research activities in exosome therapeutic by population.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Huge Investment by Automakers for Exosome Therapeutics and New Technology Penetration

Global exosome therapeutic market also provides you with detailed market analysis for every country growth in pharma industry with exosome therapeutic sales, impact of technological development in exosome therapeutic and changes in regulatory scenarios with their support for the exosome therapeutic market. The data is available for historic period 2010 to 2017.

Competitive Landscape and Exosome Therapeutic Market Share Analysis

Global exosome therapeutic market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, concept cars, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companys focus related to global exosome therapeutic market.

Many joint ventures and developments are also initiated by the companies worldwide which are also accelerating the global exosome therapeutic market.

For instance,

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for exosome therapeutics through expanded model range.

Customization Available:Global Exosome Therapeutic Market

Data Bridge Market Researchis a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.

Do You Have Any Query Or Specific Requirement? Ask to Our Industry Expert @https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=global-exosome-therapeutic-market&rp

About Data Bridge Market Research :

Data Bridge Market Researchis a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude.We are content with our glorious 99.9 % client satisfying rate.

Contact Us :

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Mail:Corporatesales@databridgemarketresearch.com

Read the original post:
Exosome Therapeutic Market is Thriving with Rising Latest Trends || Major Gaints Jazz Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH,...

Exosome therapeutic marketis expected to gain market growth in the forecast period of 2019 to 2026. Data Bridge Market Research analyses that the market is growing with a CAGR of 21.9% in the forecast period of 2019 to 2026 and expected to reach USD 31,691.52 million by 2026 from USD 6,500.00 million in 2018. Increasing prevalence of lyme disease, chronic inflammation, autoimmune disease and other chronic degenerative diseases are the factors for the market growth.

Get Sample Report + All Related Graphs & Charts (with COVID 19 Analysis) @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-exosome-therapeutic-market&pm

Exosomes are used to transfer RNA, DNA, and proteins to other cells in the body by making alteration in the function of the target cells. Increasing research activities in exosome therapeutic is augmenting the market growth as demand for exosome therapeutic has increased among healthcare professionals.

Increased number of exosome therapeutics as compared to the past few years will accelerate the market growth. Companies are receiving funding for exosome therapeutic research and clinical trials. For instance, In September 2018, EXOCOBIO has raised USD 27 million in its series B funding. The company has raised USD 46 million as series a funding in April 2017. The series B funding will help the company to set up GMP-compliant exosome industrial facilities to enhance production of exosomes to commercialize in cosmetics and pharmaceutical industry.

Increasing demand for anti-aging therapies will also drive the market. Unmet medical needs such as very few therapeutic are approved by the regulatory authority for the treatment in comparison to the demand in global exosome therapeutics market will hamper the market growth market. Availability of various exosome isolation and purification techniques is further creates new opportunities for exosome therapeutics as they will help company in isolation and purification of exosomes from dendritic cells, mesenchymal stem cells, blood, milk, body fluids, saliva, and urine and from others sources. Such policies support exosome therapeutic market growth in the forecast period to 2019-2026.

This exosome therapeutic market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for anAnalyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Competitive Landscape and Exosome Therapeutic Market Share Analysis

Global exosome therapeutic market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, concept cars, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companys focus related to global exosome therapeutic market.

The major players covered in the report are evox THERAPEUTICS, EXOCOBIO, Exopharm, AEGLE Therapeutics, United Therapeutics Corporation, Codiak BioSciences, Jazz Pharmaceuticals, Inc., Boehringer Ingelheim International GmbH, ReNeuron Group plc, Capricor Therapeutics, Avalon Globocare Corp., CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC., Stem Cells Group among other players domestic and global. Exosome therapeutic market share data is available for Global, North America, Europe, Asia-Pacific, and Latin America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many joint ventures and developments are also initiated by the companies worldwide which are also accelerating the global exosome therapeutic market.

For instance,

Partnership, joint ventures and other strategies enhances the company market share with increased coverage and presence. It also provides the benefit for organisation to improve their offering for exosome therapeutics through expanded model range.

Global Exosome Therapeutic Market Scope and Market Size

Global exosome therapeutic market is segmented of the basis of type, source, therapy, transporting capacity, application, route of administration and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

Based on type, the market is segmented into natural exosomes and hybrid exosomes. Natural exosomes are dominating in the market because natural exosomes are used in various biological and pathological processes as well as natural exosomes has many advantages such as good biocompatibility and reduced clearance rate compare than hybrid exosomes.

Exosome is an extracellular vesicle which is released from cells, particularly from stem cells. Exosome functions as vehicle for particular proteins and genetic information and other cells. Exosome plays a vital role in the rejuvenation and communication of all the cells in our body while not themselves being cells at all. Research has projected that communication between cells is significant in maintenance of healthy cellular terrain. Chronic disease, age, genetic disorders and environmental factors can affect stem cells communication with other cells and can lead to distribution in the healing process. The growth of the global exosome therapeutic market reflects global and country-wide increase in prevalence of autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases, along with increasing demand for anti-aging therapies. Additionally major factors expected to contribute in growth of the global exosome therapeutic market in future are emerging therapeutic value of exosome, availability of various exosome isolation and purification techniques, technological advancements in exosome and rising healthcare infrastructure.

Rising demand of exosome therapeutic across the globe as exosome therapeutic is expected to be one of the most prominent therapies for autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases treatment, according to clinical researches exosomes help to processes regulation within the body during treatment of autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases. This factor has increased the research activities in exosome therapeutic development around the world for exosome therapeutic. Hence, this factor is leading the clinician and researches to shift towards exosome therapeutic. In the current scenario the exosome therapeutic are highly used in treatment of autoimmune disease, chronic inflammation, Lyme disease and chronic degenerative diseases and as anti-aging therapy as it Exosomes has proliferation of fibroblast cells which is significant in maintenance of skin elasticity and strength.

For More Insights Get FREE Detailed TOC @https://www.databridgemarketresearch.com/toc/?dbmr=global-exosome-therapeutic-market&pm

Exosome therapeutic Market Country Level Analysis

The global exosome therapeutic market is analysed and market size information is provided by country by type, source, therapy, transporting capacity, application, route of administration and end user as referenced above.

The countries covered in the exosome therapeutic market report are U.S. and Mexico in North America, Turkey in Europe, South Korea, Australia, Hong Kong in the Asia-Pacific, Argentina, Colombia, Peru, Chile, Ecuador, Venezuela, Panama, Dominican Republic, El Salvador, Paraguay, Costa Rica, Puerto Rico, Nicaragua, Uruguay as part of Latin America.

Country Level Analysis, By Type

North America dominates the exosome therapeutic market as the U.S. is leader in exosome therapeutic manufacturing as well as research activities required for exosome therapeutics. At present time Stem Cells Group holding shares around 60.00%. In addition global exosomes therapeutics manufacturers like EXOCOBIO, evox THERAPEUTICS and others are intensifying their efforts in China. The Europe region is expected to grow with the highest growth rate in the forecast period of 2019 to 2026 because of increasing research activities in exosome therapeutic by population.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Huge Investment by Automakers for Exosome Therapeutics and New Technology Penetration

Global exosome therapeutic market also provides you with detailed market analysis for every country growth in pharma industry with exosome therapeutic sales, impact of technological development in exosome therapeutic and changes in regulatory scenarios with their support for the exosome therapeutic market. The data is available for historic period 2010 to 2017.

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

US: +1 888 387 2818

UK: +44 208 089 1725

Hong Kong: +852 8192 7475

Email @[emailprotected]

View original post here:
Exosome therapeutic Market Outlook 2020 (COVID 19 Impact Analysis)| Development Trends, Market Demands, Industry Analysis & Forecast by 2027 -...

The GlobalBalanced Salt SolutionsMarket study offers a comprehensive analysis of the business models, key strategies, and respective market shares of some of the most prominent players in this landscape. Along with an in-depth commentary on the key influencing factors, market statistics in terms of revenues, segment-wise data, region-wise data, and country-wise data are offered in the full study. This study is one of the most comprehensive documentation that captures all the facets of the evolving Balanced Salt Solutions market. With tables and figures helping analyze worldwide Global Balanced Salt Solutions market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.The authors of the report have also shed light on the common business tactics adopted by players. Besides that, investment opportunities, recommendations, and trends that are trending at present in the global Balanced Salt Solutions market are mapped by the report.In the regional analysis, the report highlights the prospective region, which is estimated to generate opportunities in the global Balanced Salt Solutions market in the forthcoming years. This segmental analysis will surely turn out to be a useful tool for the readers, stakeholders, and market participants to get a complete picture of the global Balanced Salt Solutions market and its potential to grow in the years to come.

Get a Balanced Salt Solutions Market Report Sample Copy @https://www.industryandresearch.com/report/Global-Balanced-Salt-Solutions-Market-Report-Insight-Key-Research-Findings-Competative-Landscape-and-Forecast-2020-2025/201676#samplereport

This comprehensive research on global Balanced Salt Solutions market is a holistic perspective of market developments, factors, dynamics, trends and challenges that decide growth trajectory of global Balanced Salt Solutions market. Factors such as industry value chain, key consumption trends, recent patterns of customer behaviors, overall spending capacity analysis, market expansion rate, etc. The report also incorporates premium quality data figures associated with financial figures of the industry including market size (in USD), expected market size growth (in percentage), sales data, revenue figures and more. This might enable readers to reach quicker decisions with data and insights at hand. In addition, the study talks about growth rate, market share and the latest developments in the Balanced Salt Solutions industry around the world. In addition, the special mention of the most important market participants contributes to the importance of the entire market study.Balanced Salt Solutions Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period.The research analysts provide an elaborate description of the value chain and its distributor analysis.

The report covers a detailed performance of some of the key players and analysis of major players in the industry, segments, application and regions Moreover, the report also takes into account the governments policies in the evaluation of the market behavior to illustrate the potential opportunities and challenges of the market in each region.The report also covers the recent agreements including merger and acquisition, partnership or joint venture and latest developments of the manufacturers to sustain in the global competition of the Balanced Salt Solutions market.This Balanced Salt Solutions Market research is categorized differently considering the various aspects of the market.Additionally, the Balanced Salt Solutions market report emphasis has been lent on current, historical, as well as future growth tendencies to make accurate growth estimations based on market size, value, volume, demand and supply trends as well as growth rate. Further as the report progresses, a dedicated section on regional overview of the Balanced Salt Solutions market is also included in the report to identify growth of market. ddtnll, th nl l h mrhnv rvw f th rul lr n th Balanced Salt Solutions rkt tgthr d thr mn rfl, W nl, ltt dvnmnt, nd bun ln. h nl vr Balanced Salt Solutions rkt nd t dvnmnt r dffrnt ndutr vrtl wll rgn. t trgt tmtng th urrnt mrkt z nd grwth tntl f th glbl Balanced Salt Solutions rkt r tn uh l ltn nd rrnttv.

Also, the competitive landscape of the Balanced Salt Solutions market is also evaluated at length in the report, to identify and analyze leading service providers. Global Balanced Salt Solutions Market reports provide in-depth analysis of Top Players, Geography, End users, Applications, Competitor analysis, Revenue, Price, Gross Margin, Market Share, Import-Export data, Trends and Forecast.The valuation of the global Balanced Salt Solutions market report represents the approximate calculation of historic verities and statistics which makes this report incredible mention for marketing, industry executives, sales and product managers, and consultants.The report study provides key statistics on the market status of the Balanced Salt Solutions manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. The report provides in-depth unique Insights with manufacturers, suppliers, distributors, traders, customers, investors and major types as well as applications and forecast period.

Competitive LandscapeThis report includes a study of the marketing and development strategies, along with the product portfolios of the leading companies. It includes the profiles of leading companies such asThermo Fisher Scientific, Lonza Group, Dickinson, EMD Millipore, Becton, Corning Life Sciences, Wheaton, PromoCell, Sigma-Aldrich, Biological. All companies analyzed in the report are studied on the basis of important factors such as market share, market growth, company size, output, sales and income. Furthermore, there is high scope for the entry of new companies, as entry barriers are not well developed. Changing consumer behavior, competition, and trade action are impacting the growth of Balanced Salt Solutions companies.

Balanced Salt Solutions Market Report: Industry Coverage:The Balanced Salt Solutions market report also analyzes the major geographic regions as well as the major countries in these regions. The regions and countries covered in the study include:* North America:The U.S., Canada, Mexico* South America:Brazil, Venezuela, Argentina, Ecuador, Peru, Colombia, Costa Rica* Europe:The U.K., Germany, Italy, France, The Netherlands, Belgium, Spain, Denmark* APAC:China, Japan, Australia, South Korea, India, Taiwan, Malaysia, Hong Kong* Middle East and Africa:Israel, South Africa, Saudi Arabia

Balanced Salt Solutions Market Segmentation Analysis:-Global Balanced Salt Solutions Market Type Segments:Hanks Balanced Salt Solution, Geys Balanced Salt Solution, Earles Balanced Salt Solution, Dulbeccos Phosphate Buffered Saline, Others

Global Balanced Salt Solutions Market Application Segments:Biopharmaceuticalstherapeutics, Stem Cell Technology, Drug Screening & Development, Genetic Engineering, Cancer Research, Others

Reason to access this report:1) This report segments the Balanced Salt Solutions market comprehensively and provides the closest market size estimation for major industries across various regions.2) The report would help stakeholders understand the pulse of the market and provide them with information on drivers, restraints, challenges, and opportunities for the market.3) This report would help stakeholders understand their competitors better and gain more insights to improve their position in the business.4) The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, and recent developments in both historic and present contexts.5) The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.6) rmr wrldwd Balanced Salt Solutions rkt mnufturng mn, t f, lrf nd nlz th rdut l munt, vlu nd mrkt hr, mrkt rvlr lnd, W nl nd dvlmnt ln nt mng r.7) The competitive landscape section includes competitor ecosystem, product launches and developments, partnerships, fund raising, and acquisitions.

Some of the key questions answered in this report:What will the market growth rate, growth momentum or acceleration market carries during the forecast period?Which are the key factors driving the Configure, Price, Quote (CPQ) Software market?What was the size of the emerging Configure, Price, Quote (CPQ) Software market by value in 2020?What will be the size of the emerging Configure, Price, Quote (CPQ) Software market in 2026?Which region is expected to hold the highest market share in the Configure, Price, Quote (CPQ) Software market?What trends, challenges and barriers will impact the development and sizing of the Global Configure, Price, Quote (CPQ) Software market?

Table of ContentsReport Overview:It includes research scope, major manufacturers covered, market segments by type, Balanced Salt Solutions market segments by application, study objectives, and years considered.Global Growth Trends:Industry trends, the growth rate of key producers, and production analysis.Balanced Salt Solutions Market Share by Manufacturer:Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.Market Size by Type:It includes analysis of price, production value market share, and production market share by type.Market Size by Application:This section includes Balanced Salt Solutions market consumption analysis by application.Profiles of Manufacturers:Here, leading players of the global Balanced Salt Solutions market are studied based on sales area, key products, gross margin, revenue, price, and production.Balanced Salt Solutions Market Value Chain and Sales Channel Analysis:It includes customer, distributor, Balanced Salt Solutions market value chain, and sales channel analysis.Market Forecast Production Side:In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

Read Detailed Index Report @https://www.industryandresearch.com/report/Global-Balanced-Salt-Solutions-Market-Report-Insight-Key-Research-Findings-Competative-Landscape-and-Forecast-2020-2025/201676

The report analysis their Sales data, Main Products, Services, and their profiles as well. Then, the report explores the international major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2013-2018 market shares for each company. Through the statistical analysis, the report depicts the global market of Balanced Salt Solutions industry including capacity, production, production value, cost/profit, supply/demand, and Southeast Asia import/export. The research experts use exclusive mixture of primary and secondary research, different analytics, and industry research to give a holistic view of the Balanced Salt Solutions market and business ecosystem. The Global Balanced Salt Solutions market exhibits comprehensive information that is a valuable source of insightful data for business strategists during the decade 2014-2025. On the basis of historical data, Balanced Salt Solutions market report provides key segments and their sub-segments, revenue and demand & supply data. Considering technological breakthroughs of the market Balanced Salt Solutions industry is likely to appear as a commendable platform for emerging Balanced Salt Solutions market investors.

At last, the study gives out details about the major challenges that are going to impact market growth. They also report provides comprehensive details about the business opportunities to key stakeholders to grow their business and raise revenues in the precise verticals. The report will aid the companys existing or intend to join in this market to analyze the various aspects of this domain before investing or expanding their business in the Balanced Salt Solutions markets.

Request customize:-If you wish to find more details of the report or want a Customization Please contacts us. You can get a detailed of the entire research here.

Contact Us @sales@industryandresearch.com

See the article here:
Balanced Salt Solutions Industry Key Drivers, Business Insights And Forecast 2026 |Thermo Fisher Scientific, Lonza Group, Dickinson, EMD Millipore -...

(STL.News) With World Sight Day, there has been an effort to increase awareness of how important it is to look after our vision. We all know that we should take regular breaks when it comes toworking on laptops and stop being on social media all the time. It is essential that our eyes get a rest.

Of course, more people are working from home now than ever before. This means it is difficult to get away from technology. So, you have to think of other ways you can adjust your lifestyle so that you can boost your eye health. In particular, eating a well-balanced diet can really help your eyes. There are vitamin-rich foods that you should incorporate into your meals every day.

Everybody knows that vitamins and minerals are good for our bodies. In particular, vitamin C is beneficial for your eyesight. It is an antioxidant that can lower the risk of macular degeneration developing, as well as cataracts. So, you are going to want to incorporate coriander into your diet. It is a herb that is full of vitamin C, as well as vitamin A, which is great for protecting the cornea.

There has been a lot of progress when it comes to treating eye conditions. For example, you can find out about what the Tej Kohli Foundation is doing to help cure blindness around theworld. But in the meantime, there are some foods you can add to your diet to help protect your vision and avoid becoming a patient of the foundation. For example, fish contains a lot of omega-three fatty acids that may help alleviate dry eye symptoms.

A portion of easy food that you can eat more of is eggs. They are packed full of vitamin A, zinc and lutein, which are all amazing for your vision. Together, they can help look after your eyes and lower the risk of problems developing later in life. For example, zinc is beneficial for helping your eyes to see better in the dark. Since you can enjoy eggs in a variety of ways, there is always going to be a way you can eat them. This could be for your breakfast, in a sandwich for lunch or as part of your evening meal.

There was probably one food that you already knew was beneficial for eye health. Of course, this would be carrots. The rumors you have heard are true and they contain vitamin A and beta carotene. Together, there are nutrients that reduce the risk of eye conditions, as well as fight off infections. Again, carrots are versatile and you can sneak them into your meals if you do not like the taste. But they do make a refreshing snack on a hot day.

Nuts and seeds are known as nutrient-rich foods. Indeed, almonds are said to be very good for maintaining good eyesight. This is due to almonds containing vitamin E. This is a nutrient that can help to safeguard your eyes from macular degeneration, and cataracts, which can lead to blindness. Almonds are an easy snack that you can enjoy when you are at home or work, as well as mixing them into your breakfast and lunch meals.

See the original post here:
Vitamin-Rich Foods that May Protect Your Eyesight - STL.News

By Puja Gupta

New Delhi Reduced eyesight is caused by multiple factors, including diseases like diabetes, eye trauma, cataracts or glaucoma.

Over 3 crore individuals suffer from blindness globally, with India being home to nearly one-third the total figure. While 80 percent vision impairment can be prevented by early detection and timely intervention, lack of access and awareness has been a major deterrent in individuals seeking eye care.

Over 5 crore people in India have moderate to severe vision impairment which has impacted their personal and professional lives, says Ramesh Pillai, Chief Optometrist & Head of Training, Titan Company Ltd, Eyewear Business. The onslaught of COVID-19 has also led to an increase in screen-time for people across ages and this has been a major factor in declining eye health. Eye care and eye health have become more of a necessity, he adds.

He suggests five simple and effective ways to ensure good eye health:

Right Glasses

Wearing branded Sunglasses which offer 100 percent UV protection while outdoors can help protect your eyes from the harmful impact of UV rays and Cataract formation. Wearing the right spectacles for screen usage like anti-reflection lenses with Blue Coating is extremely important. The Blue coating helps in blocking the harmful blue violet and allows the essential blue turquoise to help the circadian rhythm and thereby maintain the sleep-wake cycle.

Right Diet

Eating leafy green vegetables such as spinach, kale and broccoli contain Lutein and zeaxanthin help prevent cataracts. Lutein also stimulates the growth of pigments that help block out harmful UV rays. Food rich in Vitamins C and E and zinc, reduce the risk of developing a condition called Age Related Macular Degeneration (ARMD). Antioxidants protect against sun damage. Good sources of antioxidants include egg yolk, yellow peppers, pumpkins, sweet potatoes, carrots, blueberries. Onions, shallots, garlic, capers contain sulphur, cysteine, and lecithin, which help against cataract formation.

Keep Eyes Moist

Dry eyes are a major irritant, especially as the pollution gets worse day by day. Resting the eyes often and blinking moistens the eyes, reducing dryness and irritation. One can also use drops to help keep your eyes moist in case of excess dryness.

Screen Protection

With an increase in screen-time becoming an inevitable reality, taking good care of your eyes is paramount. Use the 20-20-20 rule, by taking a 20 second screen break every 20 minutes to look at objects 20 feet away from you. Increase font size when reading on-screen, so that devices dont need to be too close to your eyes, and you dont have to squint. A clean screen boosts visibility, wipe your screen over at least once a day.

Get tested

Getting your eyes tested by a qualified Optometrist or an Eye Doctor once every year is very important. Regular eye examinations help find any symptoms associated with eye strains and provide solutions for the same. Titan Eyeplus on the occasion of World Sight Day has introduced an initiative online screen testing. Take out 60 seconds and take a simple online eye screening test that will give you an indication whether you suffer from eyesight problems. Basis screening results, the brand requests all to visit an ophthalmologist or optician.(IANS)

Follow this link:
5 ways to take care of eye health - India New England

The survey, held by Johnson & Johnson Vision, found a disconnect between how the public views the importance of eye health and how regularly they attend an eye examination

Research conducted by Johnson & Johnson Vision has found that, while most UK adults acknowledge that eye examinations are important for their overall health, only a third are having their eyes examined once a year.

The most common reason for putting off appointments was because respondents felt their vision hadnt changed, while the impact of COVID-19 played a significant role in delays to appointments, Johnson & Johnson Vision found.

The company held the survey of 1002 UK adults ahead of World Sight Day on 8 October as part of Johnson & Johnson Visions Prioritise Your Eyes campaign, which aims to raise awareness of eye health.

Those surveyed appeared to recognise the importance of eye health and its impact on overall wellbeing, with results indicating that 86% of respondents view an eye exam as important for their overall health. Meanwhile 70% acknowledged that healthy vision improves quality of life, and 67% recognised that an eye exam can help prevent vision problems.

However, only 34% of those surveyed confirmed that they get an eye exam each year, something Johnson & Johnson Vision recommends to help patients to Prioritize your eyes. Just over half of respondents felt they did enough to protect their eyes.

Johnson & Johnson Vision suggested the survey results revealed a disconnect in the publics views around the importance of eye health and how they prioritise their own eye care.

Commenting on the survey, Jakob Sveen, managing director for Northern Europe and general manager for the UK & Ireland, Johnson & Johnson Vision, emphasised the companys commitment to fulfilling unmet needs in eye health, especially around awareness and access the two biggest barriers to care.

This survey has uncovered new insights and opportunities around how we, as an eye health community, can help people to prioritise their eyes by getting an annual eye exam, Mr Sveen added.

Providing reasons for why they do not get an eye exam once a year, a third of respondents explained that they put off appointments because they feel their vision hasnt changed.

The second biggest factor behind why eye care has been delayed this year was the impact of COVID-19. The survey found that 18% of adults had their appointment cancelled due to the pandemic, while 19% of respondents said they were reluctant or unable to schedule a sight test due to the pandemic. Meanwhile, 18% of survey respondents suggested cost represented a barrier for them.

Reflecting on the challenges that COVID-19 has posed in balancing the backlog of appointments, Dr Ioannis G. Tranoudis, senior director EMEA professional education solutions at Johnson & Johnson Vision, noted the agility that eye care professionals (ECPs) have shown in communicating with, and supporting, patients.

What weve seen is that emergency cases are prioritised first, so there may be a delay in being able to get everyone in quickly, Dr Tranoudis told OT. He emphasised that any patient experiencing a change in vision or with concerns should reach out to their optometrist, adding: As with all healthcare professionals in this time, ECPs have put in place new safety protocols so that patients can still receive quality care.

Moving forward, the companys focus will be in working with eye care professionals to get patients back into practice safely, he continued.

Asked what initial steps practices could take to enhance patient awareness around regular eye examinations, Dr Tranoudis highlighted: Through lockdown, I saw a lot of eye care professionals increase their communications with patients through digital channels including email updates, newsletters, through their websites, and social media.

I would encourage that, when a practice is ready and has capacity, they communicate to patients the importance of an annual eye exam, Dr Tranoudis said. Even if a patient thinks they have good vision, an annual eye exam can be one of the best things they can do for health and wellness.

Dr Tranoudis also suggested optometrists continue to reassure patients that it is safe to book an appointment if they have concerns about their eyes.

We have heard a few stories of patients being afraid to reach out during lockdown despite having a serious vision issue. ECPs can help provide reassurance by reaching out to patients proactively, suggesting that they get in touch if they have any concerns, Dr Tranoudis concluded.

The AOP recommends patients should have an eye test every two years, or more if recommended by an optometrist, and hosts a variety of resources for patientsincluding advice on regular sight tests.

Share your story

As the coronavirus pandemic transforms optometry across the UK, wed like you hear your experiences. If you, or a colleague, is interested in sharing your story, please get in touch: [emailprotected]

The rest is here:
Survey finds UK adults underestimate the need for regular eye examinations - AOP

Express News Service

BENGALURU: Good vision is a key factor for our overall health, safety, and quality of life. Though the eyes are one of the most important organs of sense in our body, people often neglect to get their eye tested regularly, unless they have some problem with their vision. Vision problems such as cataract, refractive errors, glaucoma, diabetic retinopathy, age-related macular degeneration (AMD), and retinopathy can impact people of all age groups.

Infants, school-going children, women, the elderly, people with disabilities or a family history of visual impairment, and those with chronic lifestyle disorders such as diabetes are especially vulnerable. According to data from IAPB (The International Agency for the Prevention of Blindness), early detection of vision problems can prevent more than 75 per cent of visual impairment.

Vision impairment or vision loss can affect all aspects of ones life and well-being such as performing activities at home and school, work opportunities, and interacting with family and the community. A comprehensive eye examination can help with early detection of potential eyesight problems, which could lead to vision loss and blindness if left untreated. Data from Avoidable Blindness India, a study group, indicates that about 88.2 per cent of blindness in India is avoidable.

Routine eye examinations are very essential for children at six months of age, three years of age, and five years of age to detect any potential vision abnormalities, which can be corrected in the early stage, while the childs vision system is still developing. For people over the age of 40, dilated eye exams every couple of years can help detect diseases such as glaucoma, diabetic retinopathy, and AMD in their early stages. An annual, dilated eye exam is essential for senior citizens who are at increased risk of developing degenerative age-related eye problems that cause slow but permanent damage without any noticeable symptoms.

Eye health during the pandemicEye health has taken a backseat during the coronavirus pandemic, and this could lead to permanent vision loss for those with chronic conditions such as diabetes or glaucoma. Regular follow-up visits are very important, even during this time of Covid-19, in order to monitor vision changes and ensure that any complications can be treated in the early stages to prevent vision loss. It is safe to get an eye exam or surgery done at this time as hospitals are following necessary Covid-19 safety measures such as thermal screening, social distancing of 6 feet, prior appointment system, only 1 attender per patient, use of masks and sanitizers, regular disinfection of waiting areas, testing equipment, and the OT.

Yearly check-ups by an ophthalmologist is a small investment to ensure the long term health of your eyes, and those of your family members. Timely screening can help diagnose a vision problem early and you can get treatment at the right time to avoid vision loss at a later stage. So do not neglect your annual eye check-up which can help you reduce the chance of developing serious eye problems, and keep your eyes and vision healthy in the years to come.The author is the chairman of Narayana Nethralaya

Here is the original post:
Vision 2020 - The New Indian Express

Oct 14, 2020 11:30 AM

Author: Moran Eye Center

An uninformed Halloween costume decision could haunt you for life. Were talking about disguising your eyes with freaky colored contact lenses without a prescription.

Before you go down that road, heres what you should know.

Did you know? Contact lenses of any type are medical devices that sit directly on the cornea (the clear dome of tissue over the iristhe part of the eye that gives you your eye color). Because of the risk of bacterial infections and other potential problems from poorly fitting or contaminated lenses, you should never buy any contact lenses without a valid prescription from a licensed eye care practitioner.

Its illegal to buy contact lenses without a prescription. Even if you dont need any vision correction, you still need a prescription for decorative lenses that will be a good fit.

Vendors who sell cosmetic or special-effect lenses as a type of accessory or jewelry without asking for a prescription are breaking the law and endangering your eyesight.

Cosmetic lenses need to fit correctly on your cornea; otherwise, they can be dangerous.

Any time you place something in your eye, you are risking infection, or injury, so as a general rule, I discourage the use of cosmetic lenses altogether. Even if a patient really wants them and is willing to get a proper fitting and accurate prescription, I am only OK with them being worn temporarily,saysDavid Meyer, OD, director of Contact Lens Services at the John A. Moran Eye Center at the University of Utah.

CheckFood and Drug Administration (FDA) websitewhere you can learn more and report the illegal selling of these lenses. They also warn against anime or circle lenses, saying, dont buy them and dont expect your doctor to prescribe them.

The FDA has not cleared these bigger-than-normal lenses that give the wearer a wide-eyed, doll-like look.

Poor contact lens fit can cause severe eye damage, including:

According to the FDA, you shouldneverbuy lenses from:

If your eyes start burning or itching while wearing your lenses, take them out immediately, says Meyer. See your eye doctor if you notice any pain, blurry vision, or discharge. Causing damage to your eyes for the sake of a costume is much scarier than any Halloween fright.

The John A. Moran Eye Center is a world-class institution offering some of the best patient care in the country. It is a nationally ranked care center in the Mountain West centered in Salt Lake City, Utah.

Originally posted here:
Halloween Contact Lenses: Beware! - University of Utah Health Care

The series "Imaginary Earths" speculates what the world might be like if one key aspect of life changed, be it related to the planet or with humanity itself. What might Earth be like if it had rings, or if everyone could photosynthesize like plants?

Albinism, from the Latin "albus," meaning "white," is a group of hereditary conditions with striking results a dearth and often complete absence of pigment in the eyes, skin and hair.

In the United States, about 1 in every 18,000 to 20,000 people have albinism, according to the National Organization for Albinism and Hypopigmentation (NOAH). Meanwhile, in parts of Africa such as areas within Zimbabwe, as many as 1 in 1,000 have albinism, according to the United Nations.

What might the world be like if everyone on Earth had albinism, from prehistoric times until now?

The most common form of albinism in the United States is oculocutaneous albinism, which interferes with the production of the dark pigment melanin in both the eyes and skin, according to NOAH. To date, there are seven known subtypes of this kind of albinism, which doctors have named OCA1 to OCA7, NOAH noted. Depending on the subtype, people may have white, blond or brown hair.

"I have OCA1, the most severe type of oculocutaneous albinism I have no pigment in my hair, skin and eyes," Kelsey Thompson, a rehabilitation counselor in the Chicago area, told Live Science. She previously served for 10 years on the board of directors of NOAH, including as its chair.

Related: The 7 biggest mysteries of the human body

A common myth is that people with albinism have red eyes. Although lighting conditions can make the blood vessels at the back of the eye visible, which can result in the eyes looking red or violet, most people with albinism have blue eyes, and some have hazel or brown eyes, NOAH noted. Thompson's eyes are light blue.

One key concern for people with albinism is the delicacy of fair skin. Melanin, a pigment found in hair and skin, protects skin against ultraviolet light, and people with albinism have to be wary of sunburns and skin cancer.

"When I was younger, I was a little cocky about sun exposure, and got severe sunburns," Thompson said. "Throughout my life, I've gotten in the habit of being more cautious and mindful about the sun, using sunscreen and seeking out shade as often as I can."

Related: 5 facts about skin cancer

It would be interesting to think about how perception of race might change if everyone had albinism.

So if everyone had albinism, what would happen? One scientist interviewed for this story thought this factor alone made it extremely unlikely that populations with albinism would survive over time.

"That's disappointing, but not surprising," Thompson said. "I think a lot of people who don't have the experience of living with albinism see it as they would any disability what a horrible fate to have, how it would be so awful to not do even daily tasks without struggle. But it's not a death sentence."

If everyone had albinism, people around the world might adopt long garments to protect their skin, like desert peoples in the Sahara, and hats, scarves or veils to protect their heads and faces. They might also rely on protective coatings on their skin to serve as sunscreens. The women of the Himba people in Namibia regularly wear an orange or red paste known as otjize that is made of butterfat and ochre, and often perfumed with the aromatic resin of the omuzumba shrub. Although Himba women use otjize for aesthetic reasons, I can imagine a population with albinism could conceivably create a similar paste to serve as sunscreen.

In addition, "I can imagine cultures probably evolving to do more daily activities outside the peak hours of sunlight more in the early morning and late afternoon," Thompson said.

Those with albinism might prefer to make their homes in shady environments and less sunny latitudes think Norway, not Arizona. "I still enjoy going out to the beach with my family," Thompson said. But "I do think there are parts of the world that would just be inhospitably sunny for people to even consider living there if everyone had albinism, like certain parts of the Middle East and American Southwest. Still, I do know people with albinism living in Southern California and loving it."

People with albinism have vision problems because structures within the eye rely on melanin as they develop in the womb. "My best visual acuity is 20/200, making me legally blind," Thompson said. "I have full color vision, but the details I can see are poor. It's not that things look blurry, but it's like the difference between a high-definition TV and a TV from the '80s. People with albinism can also have photophobia, or be more sensitive to glare from light."

Related: What if humans had visual acuity?

These vision problems might lead one to expect that preindustrial societies in a hypothetical past where everyone had albinism would have extraordinary difficulty surviving. "However, there's a lot of variation in vision in albinism, in what you can do," Thompson said. "I have to use certain accommodations for my vision every day, but I can function pretty independently. With albinism, an advantage we have is that we haven't lost anything with vision this is all we've ever known. To me, this is normal."

For instance, "I know people with albinism who are skilled hunters," Thompson said. "I've been involved with albinism organizations my whole life, and every time I think there's a task or job that there's no way a person with albinism can do it, sure enough, there's someone doing it."

So, if the entire human population had albinism, we might use canes, seeing-eye animals and perhaps even echolocation to help navigate the world. Still, there are people with albinism with enough functional vision to drive, Thompson noted.

"My younger brother has the same type of albinism as me, and when we sit in the optometrist's office, his vision tests pretty similarly," Thompson said. "But he adapted to it. He was even a hockey goalie. He didn't watch for the puck, but looked at the players to tell when the puck was coming toward him."

People with albinism with low vision may rely on magnifying glasses and handheld telescopes to help read, "or just hold newsprint closer to the face," Thompson said. "But a lot of the times, we use these aids to accommodate to the sighted world. If a world evolved only with people with albinism, I'd imagine all print would be large print."

Thompson does think preindustrial societies with albinism would likely rely more on agriculture than on hunting. Other possibilities include trapping and fishing with a pole or net, activities that don't require keen eyesight.

People with albinism often face stigmatization worldwide because of how they look. They are often villains in stories for instance, the evil monk Silas in "The Da Vinci Code," (Doubleday, 2003). Dozens of people with albinism have even been murdered for their body parts in Tanzania, according to The New York Times and other sources.

"Some people with albinism grow up in a very supportive environment and didn't face a lot of negativity, whereas others are pretty traumatized," Thompson said. "My experience was middle of the road not too terrible, but I did experience a lot of bullying as a kid. As an adult, it's more of a little annoyance. I get rude and invasive questions, and people wanting to touch my hair. It's really inappropriate behavior, and people normally wouldn't dream of crossing those boundaries with a total stranger, but when you have a visible difference like albinism, it comes with the territory."

Of course, in a world where everyone has albinism, there would almost certainly be no stigma attached to it. Instead, albinism might be viewed as a feature that sets humanity apart and above the rest of nature, along with language and tool use.

Related: The top 10 stigmatized health disorders

"It would be interesting to think about how perception of race might change if everyone had albinism," Thompson said. "A friend of mine from India has the same type of albinism I do, and she and I look more alike than my brother and I, even though we come from two very different ethnic backgrounds.". All in all, she suggests that if everyone had albinism, that might really change what judgments we make about each other in terms of appearance.

Albinism might influence societies other ways. "When I'm talking with a group of people who all have albinism, we do things a little differently than when functioning in the regular world," Thompson said. "When we see someone you know, I introduce myself almost like I'm on the telephone 'Hey, Matt, it's Kelsey' because we know the other person doesn't see so well. And maybe we stand a little bit closer to each other because of our poor eyesight."

Such greetings and adjustments to people's personal bubble of space might become standard features of society in a world where everyone had albinism, Thompson said.

In addition, "there's a lot of nonverbal communication that people with low vision have to be taught, like making eye contact," Thompson said. "I have nystagmus, so my eyes shake a little bit, and I have trouble seeing a person's eyes, so I was taught how to make eye contact, and think about things like not staring non-stop. Those are the kinds of things I've learned to assimilate to the sighted world."

So, if albinism was the default, the norm of making eye contact might not be a norm anymore.

"This is a really unusual mental experiment," Thompson said. "It's challenging thinking about albinism as a norm, and how that would change how that would think about the world and about myself."

Follow Charles Q. Choi on Twitter @cqchoi. Follow us on Twitter @LiveScience and on Facebook.

Original post:
What if all humans on Earth had albinism? - Live Science

According to a new study from the journal Lancet, blindness, sight loss, and severe vision impairment are predicted to double by 2050. Vision problems are estimated to affect almost 900 million people worldwide in the next few decades, which is up from approximately 338 million today.

To come to this conclusion, researchers from Anglia Ruskin University (ARU) examined more than 500 studies showing trends in the prevalence of vision loss and blindness. After reviewing this data, Professor of Ophthalmology, Rupert Bourne, was able to make forecasts about vision loss over the next three decades.

This study found that currently, 43.3 million people are blind, 295.1 million people have major vision impairment, and 257.8 million are mildly visually impaired. While previous studies have shown that the prevalence of blindness among the over 50s has reduced by 28.5% globally over the past 30 years, population growth means these numbers will increase. An estimate by researchers states that with this population growth, the number of blind people may increase by 50.6%, and the number of people with major visual impairment is believed to almost double.

By using these models, the authors of this study predict a considerable rise in the number of people with severe visual impairment or sight loss in the next 30 years. They do, however, state that these numbers can be prevented if major steps are taken to address the problem.

Professor Bourne, co-ordinator of the Vision Loss Expert Group, spoke about the findings, It is encouraging that age-adjusted prevalence of blindness has reduced over the past three decades, yet due to population growth, progress is not keeping pace with needs. We face enormous challenges in avoiding vision impairment as the global population grows and ages. One of the issues we faced when compiling this data is that for many countries, including the UK, there is a lack of accurate information due to the fact the population has not been officially surveyed for eye disease and its consequences. High quality, current data on eye health and also hearing loss, is needed so the UK can plan future services in the most effective way, improve outcomes for those affected, and develop a more effective public health strategy in these crucial areas. Without this, the provision of services is a postcode lottery as we dont understand the unmet need.

With the rising numbers of vision impairment and blindness possible in the near future, it is imperative that people start taking the health of their eyes seriously. There are many reasons why vision could be affected as we age, including environmental factors, food choices, and even prolonged blue light exposure. By learning how to protect the eyes from future damage, it may make all the difference in keeping your eyesight healthy for a lifetime.

Continue reading here:
Blindness and Sight Loss Is Projected to Double by 2050 - Bel Marra Health

New Delhi:On World Sight Day, which is celebrated every year on the second Thursday of October month, a spectacles distribution programme for Government School children in Chittapur Taluk of Kalburagi district was organized by Samadhristi, Jaya Foundation, SightRyt and Essilor Vision Foundation.

Mr. Priyank Kharge, MLA, of Chittapur, inaugurated the program and opined that if we can provide required infrastructure to the Schools, only then will the future of the students be bright and this can automatically lead to a growth of the nation.

Mr. Kharge said that when K Ullas Kamath from Jaya Foundation showed interest to find a remedy for these students whose eyesight can be corrected simply by providing spectacles, he utilised the opportunity and got 26,000 students in his taluk tested; out of which 1426 children were suffering from eye sight problems and they have been distributed necessary prescribed spectacles.

He felt, it is not enough to rectify the problem of children eyesight problems, but also to change the thought process of parents. Children should be educated properly, and scientific approach should be developed among them, which will help for the future of this country. He requested parents not to demoralize the children with eyesight problems, instead find a permanent solution.

Mr. K Ullas Kamath of Jaya Foundation said that upto 30% of students suffer from eyesight problems and their parents never come across this information. He further said that the Foundation provides spectacles to those children at no cost to them.

The Director of Sightryt, Mr. Sidharth Pai and Mr. Shiva Kumar Janardhan, CEO of Sightryt Organisation expressed their thoughts to the same effect.

Milind Jadhav, Trustee, Essilor Vision Foundation, India, said, During this difficult times of pandemic, Good vision is key to helping children succeed in academics. A simple eye examination can identify eye-related issues, if found early enough, many of which can be treated with a pair of simple spectacles.

Read the original post:
On World Sight Day, around 1500 Government school children, identified with vision issues were given spectacles at no cost to them - India Education...

For individuals suffering from vision loss, low vision rehabilitation is the standard of care. Because of the spread of SARS-CoV-2, doctors of optometry must develop new techniques to provide low-vision rehabilitative services with safer protocols.

This is an unprecedented time in optometric and vision rehabilitation care for all providers and patients. I have been an optometrist practicing low vision rehabilitation for more than 15 years at The Chicago Lighthouse, where our comprehensive vision rehabilitation clinic serves more than 3500 patients each year.

While reviewing the guidance from the U.S. Centers for Disease Control and Prevention (CDC), Occupational Safety and Health Administration (OSHA), and our optometric associations, I noticed that these recommendations do not accommodate people with visual disability. It is imperative that optometrists offering vision rehabilitation services consider additional accommodations for this large patient population during the novel coronavirus (COVID-19) pandemic and recovery. I share some recommendations here.

More from October 2020's issue: Protect patients eyes by encouraging a three-step ocular wellness regimen

Mental health effects

Age-related eye diseases are the leading cause of blindness and low vision in the United States.1 As such, most patients referred for vision rehabilitation fall into the population over age 65 years that the CDC currently advises to continue to stay home and avoid close contact with others whenever possible.2

ODs can continue to offer telehealth visits where possible but realize that some patients will need to be seen for both their vision health and mental health.

Depression is strongly associated with functional vision loss.3 Social isolation is linked with poor mental health, and results of a recent poll show that 47 percent of people sheltering in place reported negative mental health effects from worry or stress related to the novel coronavirus.4

Strategies people may use to cope and relax such as TV watching, reading, and exercise can be challenging or even impossible for persons with vision impairment who do not yet have optical or assistive technology. The combination of being sight isolated and socially isolated may compound negative mental health effects.

Vision rehabilitation may have an antidepressant effect.5 Ensure that patients whose care has been delayed during the pandemic are not experiencing additional emotional and psychological consequences. Ask your patient if she feels anxious or depressed. If this is the case, you may want to, in advance of your examination, make a referral to a mental health professional currently offering telehealth services.

Related: Smart contact lens update

Telehealth

If it is unsafe to bring a patient with low vision into the office, consider a telehealth visit, which is covered by Medicare and by many third-party insurers during this COVID-19 pandemic.6 A prescription for a magnification device to be mailed to the patient can be based off the last known best corrected visual acuity. Training in use of the device may be done virtually if the patient has access to computer technology or on the telephone. This telehealth strategy may restore some interim reading ability while a patient stays at home until it is safe to visit the office.

Accommodations during office visits

As many low vision providers return to seeing patients in the office, ODs should think about the specific needs of these patients and how to safely meet them.

Following are suggestions in addition to general COVID-19 guidance from the American Optometric Association.7

Related: In vivo bulbar conjunctival structures study results in

Prepare patients for in-office changes

and screen for mental health effects

Contact patients before their examination and educate them on what changes to expect because of COVID-19 restrictions. Preparing them will help prevent surprise and unneeded anxiety during the appointment.

Patient registration and payment

Reserve first-of-the-day appointments for elderly and other patients at high risk of COVID-19.

If practices recently began using an online portal for patients to preregister and/or pay bills and copays, ensure that patients can use this technology and consider barriers to successful use. Determine whether this portal is compatible with common screen magnification and screen readers. Can the patient see his insurance cards and credit cards?

Ask if patients are familiar with accessibility software or know where to obtain it. Many patients are referred to ODs for vision rehabilitation to learn about these resources and do not have them before the examination.

For patients who cannot access online portals themselves, consider completing the registration and history over the phone.

Make concessions for accepting payments in person for patients who prefer to do so or who cannot access online payment.

Related: Improve medication adherence with technology

Patient entrance

Current public health recommendations suggest allowing only the patient into the officeno family members except for guardians of minors. In vision rehabilitation, however, ODs most often encourage a person or coach to accompany the patient because for many elderly patients with age-related cognitive changes, a second set of ears or a note taker to capture information given is helpful.

Many patients are newly referred and do not yet have mobility skills that make them comfortable to ambulate without a sighted guide. Furthermore, some eyecare practices are calling patients in from their cars to avoid waiting room congregation where possible. Many patients do not drive, so waiting in a car may not be possible, and weather conditions may prevent them from waiting outside.

Allow patients who cannot wait in a car into the waiting room, with chairs spaced an appropriate distance apart.7

Consider allowing one appropriately screened family member to accompany the patient to the appointment.7

For those who do not have someone to accompany them, determine whether a staff member will act as a sighted guide. This can be done in 1 of 3 ways. The guide can speak directions while maintaining social distancing. For cane users, the guide and the patient can hold opposite ends of a white cane between them. For persons needing further support, the guide and the patient should both wear a mask and gloves so the patient can hold onto the guide.

Related: Distinguish between wellness and medical eye exams

The examination

White coats that need laundering are now discouraged, as is dry-clean-only business attire. The white coat with its high contrast might have signaled to poorly-sighted patients that the doctor was in the room. Wearing a mask, gloves, and scrubs and/or street clothes, with no handshake7 but just an introduction from 6 ft (2 m) away leaves the patient with vision impairment at a disadvantage.

Low vision providers usually get physically close to our patients so they can take advantage of relative distance magnification and perhaps see some of our features. Physical closeness, however, is discouraged in this climate. Wearable video magnification devices, including electronic glasses, for visually impaired individuals require training to use successfully, may be difficult to disinfect, and may be cost prohibitive to have in each examination lane. Other options may be better.

As ODs take the patients histories at a distance, tell them it is for their safety.

Consider giving patients a photocard of the doctor that they may view from a closer distance.

Perhaps use a closed-circuit TV camera pointed at the OD across the room with a screen beside the patient so the patient can see the doctors features and gestures magnified.

ODs should consider wearing a facial shield in addition to a mask to allow them to be closer to the patient when needed, especially during trial frame refraction and device evaluation.

Wear gloves and have patients wear gloves when evaluating low vision devices. Disinfect all instruments after each use.7

Work to convey a calm and pleasantness with the voice, offering the reassurance vision-imapired patients so desperately need.

Provide written educational resources for patient reference at the end of the visit.

Grateful, anxiety-relieving hugs from patients are not uncommon. Unfortunately, physical contact is no longer considered safe. Still, try to earn the hugs and then kindly decline them, reinforcing the importance of social distancing.

Follow-up

Consider a phone follow-up to review the examination findings with a coach or family member if that person was not present at the examination.

Send a written thorough rehabilitation plan with patient goals.

As COVID-19 restrictions are lifted, consider a more frequent follow-up interval to ensure goals were not overlooked in haste during a shortened examination.

Refer a patient for home-based occupational therapy as needed. The American Occupational Therapy Association lists recommendations for safe provision of home-based care, which is still allowed.8 Home care will allow vision-impaired patients to follow stay-at-home guidelines while receiving additional occupational therapy training.

Related: More research coming on drug delivery via contact lenses

Summary

Patients needing visual rehabilitation are looking to optometrists for their health and safety in living with low vision. Deferring care and providing care must be balanced.

In the era of COVID-19, optometry visits have visibly changed to maintain safety recommendations. ODs need to ensure that these changes for patients with visual challenges accommodate their particular needs.

References

1. Centers for Disease Control and Prevention. Common eye disorders. Available at: https://www.cdc.gov/visionhealth/ basics/ced/index.html. Accessed 9/18/20.

2. Centers for Disease Control and Prevention. How to Protect Yourself & Others. Available at: https://www.cdc.gov/ coronavirus/2019-ncov/need-extra-precautions/what-you-can-do.html. Accessed 9/18/20.

3. Zhang X, McKeever Bullard K, Cotch MF, Wilson MR, Rovner BW, McGwin Jr G, Owsley C, Barker L, Crews JE Saaddine JB. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005-2008. JAMA Ophthalmol. 2013 May;131(5):573-581.

4. Panchal N, Kamal R, Orgera K, Cox C, Garfield R, Hamel L, Muana C, Chidambaram P. The implications of COVID-19 for mental health and substance use. Kaiser Family Foundation. Available at: https://www.kff.org/coronavirus-covid-19/issue-brief/the-implications-of-covid-19-for-mental-health-and-substance-use/. Accessed 9/18/20.

5. Horowitz A, Reinhardt JP, Boerner K. The effect of rehabilitation on depression among visually disabled older adults. Aging Ment Health. 2005 Nov;9(6):563-570.

6. Centers for Medicare and Medicaid Services. Is my test, item, or service covered? Available at: https://www.medicare. gov/coverage/telehealth. Accessed 9/18/20.

7. American Optometric Association. COVID-19 latest updates. Available at: https://www.aoa.org/covid-19/covid-19-latest-updates?sso=y. Accessed 9/25/20.

8. American Occupational Therapy Association. Home health occupational therapydecision guide for COVID-19. Available at: https://www.aota.org/~/media/Corporate/Files/Practice/ Health/COVID-19-Home-Health-Decision-Guide.pdf. Accessed 9/18/20.

Read the original post:
Vision rehabilitation care for low vision patients in the COVID-19 era - Optometry Times

Marc Ferrara, CEO of Information Services, Jobson Medical Information, named recipient of the 2021 Prevent Blindness Person of Vision Award.

CHICAGO (PRWEB) October 14, 2020

Prevent Blindness, the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight, has chosen Marc Ferrara, CEO of Information Services, Jobson Medical Information, as the recipient of the 2021 Prevent Blindness Person of Vision Award. The award will be presented on Wed., May 26, 2021, at the Prevent Blindness Person of Vision Dinner at 583 Park Avenue, New York, N.Y., in conjunction with Vision Expo East. All proceeds from the event will go to support the sight-saving programs from Prevent Blindness.

The Prevent Blindness Person of Vision Award recognizes an individual or organization whose inspired outlook champions healthy vision and its importance for a healthy life.

Marc Ferrara has worked at Jobson Publishing for more than 30 years. In 1989, he was named editor-in-chief of 20/20 magazine and was later named publisher of the magazine. Later, he helped launch Sightstreet, one of the optical industry's initial ventures in web-related initiatives, and later managed VisionWeb, the industry's leading wholesale portal. Mr. Ferrara served as president of JHI's worldwide Optical Group since 2005, with wide-ranging responsibilities including 20/20, Frames Data, Vision Monday, Review of Optometry, Review of Ophthalmology, Jobson Research, Jobson Internet Solutions and Jobson's international business in Europe, Latin America and Asia.

At Prevent Blindness, Mr. Ferrara has served on various committees including as Chair of the 2017 Person of Vision Committee, honoring Marge Axelrad, senior vice president, editorial director at Vision Monday/Jobson Optical Group. He has also volunteered for numerous Prevent Blindness events, including the annual Swing Fore Sight golf outings.

Marc Ferrara has been a true leader and influencer in the optical and vision industry for decades, said Jeff Todd, president and CEO of Prevent Blindness. We congratulate him on receiving the 2021 Person of Vision Award and look forward to seeing everyone back in New York in May!

Sponsorship opportunities are now available. The Prevent Blindness Person of Vision Committee is currently being formed.

For more information including Prevent Blindness Person of Vision Award committee membership, sponsorship opportunities, and reservations, please contact Sue Corbett at (312) 363-6014 or scorbett@preventblindness.org or visit https://preventblindness.org/events/person-of-vision-2021/.

About Prevent Blindness Founded in 1908, Prevent Blindness is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening and training, community and patient service programs and research. These services are made possible through the generous support of the American public. Together with a network of affiliates, Prevent Blindness is committed to eliminating preventable blindness in America. For more information, or to make a contribution to the sight-saving fund, call 1-800-331-2020. Or, visit us on the Web at preventblindness.org or facebook.com/preventblindness.

Share article on social media or email:

See the original post here:
Prevent Blindness Names Marc Ferrara of Jobson Medical Information, as 2021 Person of Vision Award Recipient - PR Web

As the coronavirus pandemic continues, precautions are being taken to safeguard Queen Elizabeth's health, as her age puts her at risk for severe illness should she contract COVID-19. But despite social distancing at Windsor Castle, the British monarch is continuing to work, and to take her duties seriously.

Yesterday, she joined her daughter-in-law, Sophie the Countess of Wessex, on a video call for a conversation to mark World Sight Day. Sophie is the Global Ambassador for the International Agency for the Prevention of Blindness, a cause close to her heart as her daughter Lady Louise has overcome a condition of the eyes known as strabismus.

"Her squint was quite profound when she was tiny and it takes time to correct it," Sophie shared in an interview several years ago. "You've got to make sure one eye doesn't become more dominant than the other but she's fine nowher eyesight is perfect."

Per Buckingham Palace, the pair of royal women spoke with leaders in the eye health fields, "about the powerful impact that good quality eye care can have on peoples livesenabling children to benefit from education; working adults to keep their jobs; and older people to participate in their families and communities."

The group also "discussed the challenges the sector has faced during recent months as a result of the global pandemic," and "shared their hopes for the future and the opportunities and innovations that will continue to improve eye care and strengthen eye health in the next decade."

News of the video call comes shortly after Buckingham Palace confirmed that Sophie is self-isolating following contact with someone who subsequently tested positive for COVID-19.

Earlier today a spokesperson released the following statement:

She has not been in physical contact with her mother-in-law Queen Elizabeth since she was in contact with said person.

This content is created and maintained by a third party, and imported onto this page to help users provide their email addresses. You may be able to find more information about this and similar content at piano.io

Read more:
Queen Elizabeth and Sophie, the Coutess of Wessex Team Up for a Joint Video Call - TownandCountrymag.com

A lot of modern technologies are designed for the vast majority of people with more or less capable vision and motor skills. Smartphones, for example, presume everyone has agile and accurate fingers, not to mention good if not excellent eyesight. Even laptops with larger screens take for granted that not everyone sees the same way. To make its web-centric platform more inclusive, Google is pouring some attention on accessibility features for Chrome OS that specifically target those who arent able to see well.

A lot of attention has been given to colors in new design languages but the fact is that not everyone sees colors the same way. Some might not even be able to distinguish some colors because of contrast problems. To remedy that for one of the smallest parts of the desktop interface, Chrome OS now lets users change not only the size of the mouse cursor but even its color, making the icons easier to see and locate on the screen.

It isnt just icons that are hard to see, of course. Words are sometimes trickier to make out, even with something like text-to-speech or TTS technologies. Chrome OS is augmenting this accessibility feature by highlighting the selected text that will get spoken, making the words visually pop out. This additional aid can help those with low vision but can even help some with learning disabilities, whether they have good eyesight or not.

And for those that are barely able to see at all, Google has improved its ChromeVox Chrome OS screen reader to speak in the language that a web page is set to. It also boasts that Chrome is the first browser that creates PDFs with headings, links, and tables that can help screen readers better analyze the text and speak it out for users.

These features are rolling out in the latest Chrome OS version and if you feel lost in all of it, Google has also launched a new Accessibility Hub for Chromebooks as your guide. These may seem like small changes that wont exactly benefit the vast majority of users but, sooner or later, well all come to a point when well need all the help we can get even to just use a computer or a phone.

Go here to read the rest:
Chrome OS 86 aims to make computing more accessible to visually impaired - SlashGear

The drive from Big Sandy to Great Falls is awfully familiar to our family. Jon drives those 70-some miles twice a week as he travels between our farm and the Senate. Often we drive together for farm parts, haircuts, you name it. The drive is second nature. But lately, it has taken on a new meaning.

Because in early spring of this year, I was diagnosed with breast cancer.

I found the cancer as many women do, with a lump. But I had a bit of a head start: breast cancer runs in my family both my grandmothers had breast cancer, and my grandmother on my mothers side, my mother, my sister, myself, and my daughter all have the same breast cancer gene. The knowledge that its genetic has helped serve as preventative medicine for our family once I knew I was likely to get it, it empowered me to know what to look for and get screened regularly.

Cancer doesnt discriminate between gender or age, and breast cancer is no exception.

Men get it too, and it isnt shameful to talk about it, because men need to be aware of their own risk factors.

When it comes to breast cancer, monthly self-examinations are critical, because if caught early, it can save your life.

I knew from the beginning that my prognosis was good, and was lucky to feel full mostly of hope, not fear. This month, I completed my final round of chemotherapy, and I have been very lucky to have few side effects. My husband and kids have been a remarkable support system.

The love and support of my family gave me the strength to face the uncertainties of cancer head-on. And at the end of the day, I know that Im fortunate. Fortunate to have been blessed by the doctors, nurses, and health care workers at Benefis Sletten Cancer Institute in Great Falls that have given me top-notch care every step of the way. They were both professional, and personal, and made sure that every time I walked in those doors I never felt a sense of doom and gloom. And I feel more fortunate, still, that in a state where some folks have to travel for hundreds of miles to receive care, our 70-some mile drive was a pretty short hop.

And when youre counting your blessings, its hard not to consider those that arent as fortunate.

How many Montanans face the fear of cancer diagnosis without the security of affordable health care? How many folks skip cancer screenings or go without treatment because a trip to the doctor would mean the choice between paying a medical bill or putting food on the table?

Its only fitting that I received the last of my treatment during Breast Cancer Awareness Month. I encourage everyone, women and men alike, to use this month as a reminder to take precautionary steps. Check yourself often. Get regular screenings. Early detection can save your life.

Now that my treatment is finished, the drive to Great Falls will be easier again. I still have work in front of me and the outlook is promising. But the many cancer patients with a tough road ahead will still be on my mind and in my prayers.

I am not fighting my battle alone, and no Montanan ever should.

Sharla Tester is a farmer living and working in Big Sandy. She is married to U.S. Senator Jon Tester.

Link:
Early detection of breast cancer saves lives | State | sidneyherald.com - Sidney Herald Leader